Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities

References

• Sporer KA. Acute heroin overdose. Ann Intern Med 1999;130:584-90
   PubMed Web of Science ®Google Scholar
• Coffin PO. Overdose: a major cause of preventable death in central and Eastern Europe in Central Asia: recommendations and overview of the situation in Latvia, Kyrgyzstan, Romania, Russia and Tajikistan. Vilnius, Lithuania: Eurasian Harm Reduction Network, 2008
   Google Scholar
• Auriacombe M, Franques P, Tignol J. Deaths attributable to methadone vs buprenorphine in France. JAMA 2001;285:45
   PubMed Web of Science ®Google Scholar
• Rhodes T, Sarang A. Drug treatment and the conditionality of HIV treatment access: a qualitative study in a Russian city. Addiction 2012;107:1827-36
   Google Scholar
• Marshall BD, Milloy MJ, Wood E, et al. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011;377:1429-37
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sherman S, Curtis M. Underestimated and overlooked: a global review of drug overdose and overdose prevention. London, England: International Harm Reduction Association, 2010
   Google Scholar
• Strang J, Kelleher M, Best D, et al. Emergency naloxone for heroin overdose. BMJ 2006;333:614-5.
   PubMed Web of Science ®Google Scholar
• Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007;49:172-7
   PubMed Web of Science ®Google Scholar
• Gonzva J, Prunet B, Deniel C, et al. Early antidote use associated with noninvasive ventilation in prehospital treatment of methadone intoxication. Am J Emerg Med 2013;31:448 e5-6.
   Google Scholar
• Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008;103:979-89
   PubMed Web of Science ®Google Scholar
• Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99:788-91
   PubMed Web of Science ®Google Scholar
• Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008;43:858-70
   PubMed Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010;87:931-41
   PubMed Web of Science ®Google Scholar
• Sherman SG, Gann DS, Scott G, et al. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J 2008;5:2-6
   PubMed Web of Science ®Google Scholar
• Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25:89-96
   PubMed Web of Science ®Google Scholar
• Paone D, Heller D, Olson C, et al. Illicit drug use in New York City. NYC Vital Signs New York, NY: Department of Mental Health and Hygeine, 2010. p 1-4
   Google Scholar
• Coffin PO, Tracy M, Bucciarelli A, et al. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med 2007;14:616-23
   PubMed Web of Science ®Google Scholar
• Stout NK, Knudsen AB, Kong CY, et al. Calibration methods used in cancer simulation models and suggested reporting guidelines. PharmacoEconomics 2009;27:533-45
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 2013;158:1-9
   PubMed Web of Science ®Google Scholar
• Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006
   Google Scholar
• Huo D, Bailey SL, Ouellet LJ. Cessation of injection drug use and change in injection frequency: the Chicago Needle Exchange Evaluation Study. Addiction 2006;101:1606-13
   PubMed Web of Science ®Google Scholar
• Bruneau J, Brogly SB, Tyndall MW, et al. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 2004;99:727-37
   PubMed Web of Science ®Google Scholar
• Sergeev B, Karpets A, Sarang A, et al. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003;80:212-9
   PubMed Web of Science ®Google Scholar
• Grau LE, Green TC, Torban M, et al. Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia. Harm Reduct J 2009;6:17-28
   PubMed Web of Science ®Google Scholar
• Green TC, Grau LE, Blinnikova KN, et al. Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy 2009;20:270-6
   PubMed Web of Science ®Google Scholar
• Kwon JA, Iversen J, Maher L, et al. The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis. J Acquir Immune Defic Syndr 2009;51:462-9
   PubMed Web of Science ®Google Scholar
• Ochoa KC, Davidson PJ, Evans JL, et al. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend 2005;80:297-302
   PubMed Web of Science ®Google Scholar
• Jenkins LM, Banta-Green CJ, Maynard C, et al. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health 2011;88:118-28
   PubMed Web of Science ®Google Scholar
• Galea S, Coffin PO. Drug overdose: new insights, innovative surveillance, and promising interventions. J Urban Health 2003;80:186-8
   Google Scholar
• Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust 1996;164:204-7
   PubMed Web of Science ®Google Scholar
• Wu LT, Woody GE, Yang C, et al. Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil 2011;2011:77-88
   Google Scholar
• Open Health Institute. Harm reduction programs in the civilian and prison sectors of the Russian Federation: assessment of best practices. Moscow: World Bank, 2006
   Google Scholar
• Musatov VA. Abstinence from drugs vs reducing harm. Sixth School for Journalists Writing on Health Issues. Pushkino School for Journalism: Pushkino, Russia, 2006
   Google Scholar
• Cohen J. No opiate substitutes for the masses of IDUs. Science 2010;329:165-7
   Google Scholar
• Hser YI. Drug use careers: recovery and mortality. In Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance use by older adults: estimates of future impact on the treatment system. OAS Analytic Series #A-21, DHHS Publication No. (SMA) 03-3763. Rockville, MD: SAMHSA 2002
   Google Scholar
• Evans JL, Hahn JA, Lum PJ, et al. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend 2009;101:152-7
   PubMed Web of Science ®Google Scholar
• Pollini RA, McCall L, Mehta SH, et al. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend 2006;83:104-10
   PubMed Web of Science ®Google Scholar
• Darke S, Williamson A, Ross J, et al. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J Urban Health 2007;84:283-91
   PubMed Web of Science ®Google Scholar
• Abdala N, Grund JP, Tolstov Y, et al. Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union? Addiction 2006;101:731-7
   PubMed Web of Science ®Google Scholar
• Darke S, Mills KL, Ross J, et al. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug Alcohol Depend 2011;115:190-5
   PubMed Web of Science ®Google Scholar
• Stoove MA, Dietze PM, Jolley D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev 2009;28:347-52
   PubMed Web of Science ®Google Scholar
• Milloy MJ, Kerr T, Mathias R, et al. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse 2008;34:499-509
   PubMed Web of Science ®Google Scholar
• Gossop M, Griffiths P, Powis B, et al. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ 1996;313:402
   PubMed Web of Science ®Google Scholar
• Davidson PJ, McLean RL, Kral AH, et al. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J Urban Health 2003;80:261-73
   PubMed Web of Science ®Google Scholar
• Coffin PO. Overdose and femoral injection among Seattle-area injection drug users. In: National Institute on Drug Abuse, ed. Epidemiologic trends in drug abuse. Proceedings of the Community Epidemiology Work Group. Rockville, MD, June 2011
   Google Scholar
• Coffin PO, Galea S, Ahern J, et al. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction 2003;98:739-47
   PubMed Web of Science ®Google Scholar
• Avksentieva MV, Antonova NV, Arutyunov GP, et al. Procedure for clinical and economic evaluation of drug lists that are submitted for reimbursement coverage from public health care budget. Russia: Research center for clinical and economic evaluation and pharmacoeconomics of the Russian State Medical University; 2010
   Google Scholar
• Tsarev SA. Annual Report: preventing opiate overdose among injecting drug users in Chapayevsk. Chapayevsk, Russian Federation: Open Society Institute, 2010
   Google Scholar
• Gorbunova Y. Summary of naloxone distribution activities. Naberezhnye: Tamur Islamov Charitable Fund, 2010
   Google Scholar
• Tufts G. Return of the ambulance. Moscow, Russia: Rossijskaya Gazeta, 2011
   Google Scholar
• Russian Federation Ministry of Health and Social Development. Health/Medical Insurance; Information Letter on the formation and economic justification of territorial programs providing government guarantees for free healthcare for Russian citizens in 2011. Moscow, Russia: Russian Federation Ministry of Health and Social Development; 2012
   Google Scholar
• Winter Y, Epifanova-Bertschi N, Sankowski R, et al. Health-related quality of life and its determinants in the urban Russian population with major depressive disorder: a cross-sectional study. Int J Psychiatry Med 2012;43:35-49
   Google Scholar
• Nosyk B, Sun H, Guh DP, et al. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol 2010;63:1132-44
   PubMed Web of Science ®Google Scholar
• Pyne JM, Tripathi S, French M, et al. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes. Addiction 2011;106:507-15
   PubMed Web of Science ®Google Scholar
• Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87
   PubMed Web of Science ®Google Scholar
• Tamatsukuri S, Suzuki T, Kasai K, et al. [A novel RNA capture method for the extraction of HCV-RNA]. Kansenshogaku Zasshi 1996;70:479-84
   Google Scholar
• United States Agency for International Development. Russia: HIV/AIDS Health Profile. Moscow, Russia: USAID/Russia; 2010. p 4
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS, 2010
   Google Scholar
• Williams-Sherlock M. Universal access to HIV prevention, treatment, care, and support: 2011 Progress Report, Europe and Central Asia. Geneva: Joint United Nations Programme on HIV/AIDS, 2012
   Google Scholar
• Krupitsky EM, Zvartau EE, Lioznov DA, et al. Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addict Res 2006;12:12-19
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Control: Russian Federation Country Profile. Geneva: World Health Organization, 2011
   Google Scholar
• Maher L, Jalaludin B, Chant KG, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006;101:1499-508
   PubMed Web of Science ®Google Scholar
• Galea S, Worthington N, Piper TM, et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav 2006;31:907-12
   PubMed Web of Science ®Google Scholar
• Coffin PO, Coffin LM, Fitzpatrick T, et al. Drug overdose, lay naloxone, and HIV risk behaviors among persons who inject drugs. XIX International AIDS Conference. Washington, DC, 2012. Abstract#MOPE218
   Google Scholar
• McAuley A, Best D, Taylor A, et al. From evidence to policy: The Scottish national naloxone programme. Drugs Educ Prev Policy 2012;19:309-19
   Web of Science ®Google Scholar
• Wall M, Schmidt E, Sarang A, et al. Sex, drugs and economic behaviour in Russia: a study of socio-economic characteristics of high risk populations. Int J Drug Policy 2011;22:133-9
   Google Scholar
• Mackesy-Amiti ME, Ouellet LJ, Golub ET, et al. Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction 2011;106:601-8
   PubMed Web of Science ®Google Scholar
• The future of harm reduction programmes in Russia. Lancet 2009;374:1213
   Google Scholar
• Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010;21:186-93
   PubMed Web of Science ®Google Scholar
• Davidson PJ, Ochoa KC, Hahn JA, et al. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction 2002;97:1511-6
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 1996;91:405-11
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Tracy M, Galea S. Characteristics of drug users who witness many overdoses: implications for overdose prevention. Drug Alcohol Depend 2012;120:168-73
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina DK, McManus J, et al. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care 2011;15:320-4
   PubMed Web of Science ®Google Scholar
• Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008;103:1648-57
   PubMed Web of Science ®Google Scholar
• Tobin KE, Sherman SG, Beilenson P, et al. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009;20:131-6
   PubMed Web of Science ®Google Scholar
• Teesson M, Mills K, Ross J, et al. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008;103:80-8
   PubMed Web of Science ®Google Scholar
• Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000;90:1100-11
   PubMed Web of Science ®Google Scholar
• Vanagas G, Padaiga Z, Bagdonas E. Cost-utility analysis of methadone maintenance treatment in Lithuania. Medicina (Kaunas) 2010;46:286-92
   PubMed Web of Science ®Google Scholar
• Koshkina EA. Mortality associated with drug use. Use of Epidemiologic Methods for Drug User Mortality Research. Petrozavodsk, Russia: United Nations Office on Drugs and Crime, 2008
   Google Scholar
• Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995;40:139-50
   PubMed Web of Science ®Google Scholar
• Hser YI, Hoffman V, Grella CE, et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503-8.
   PubMed Web of Science ®Google Scholar
• Vlahov D, Wang C, Ompad D, et al. Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse 2008;43:413-28
   PubMed Web of Science ®Google Scholar